9 companies

Illumina

Market Cap: US$28.4b

Provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa.

New

ILMN

US$187.96

7D

-8.4%

1Y

98.8%

Elanco Animal Health

Market Cap: US$11.1b

An animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide.

New

ELAN

US$22.12

7D

-16.1%

1Y

32.7%

Bruker

Market Cap: US$7.8b

Develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions.

New

BRKR

US$53.41

7D

-15.0%

1Y

75.5%

Tyra Biosciences

Market Cap: US$1.6b

A clinical-stage biotechnology company, develops precision medicines for fibroblast growth factor receptor (FGFR) biology in the United States.

New

TYRA

US$26.51

7D

-16.8%

1Y

153.7%

Faeth Therapeutics

Market Cap: US$631.1m

A clinical-stage biotechnology company, engages in the discovery and development of therapeutics for cancer patients.

New

FTH

US$24.39

7D

-10.5%

1Y

218.8%

Zentalis Pharmaceuticals

Market Cap: US$355.9m

A clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers in the United States.

New

ZNTL

US$4.23

7D

-10.8%

1Y

193.8%

Coherus Oncology

Market Cap: US$196.2m

A biopharmaceutical company, researches, develops, and commercializes immunotherapies to treat cancer in the United States.

New

CHRS

US$1.27

7D

-9.9%

1Y

54.7%

Fortress Biotech

Market Cap: US$88.7m

Operates as a biopharmaceutical company in the United States and internationally.

New

FBIO

US$2.67

7D

-14.7%

1Y

46.7%

Exousia Bio

Market Cap: US$21.0m

A biotechnology company, designs, develops, and manufactures mammalian- and plant-derived exosomes using proprietary technologies for nucleic acid loading and targeted delivery to tissues and cells.

New

LMMY

US$0.40

7D

-8.7%

1Y

122.1%